about
Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic ToolsInteraction of Intestinal Microorganisms with the Human Host in the Framework of Autoimmune DiseasesAnimal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human PathologyA model for lupus brain diseaseIL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone MiceAnti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studiesReview: basics of drug development in rheumatologyPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusSilica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 MouseThe endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeabilityEarly Ovariectomy Results in Reduced Numbers of CD11c+/CD11b+ Spleen Cells and Impacts Disease Expression in Murine Lupus.Pin1-Targeted Therapy for Systemic Lupus ErythematosusMesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic propertiesGerminal center B cell depletion diminishes CD4+ follicular T helper cells in autoimmune miceNew insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseasesGenetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus.Dynamics of gut microbiota in autoimmune lupusFli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activationMechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.The role of cytokine in the lupus nephritis.The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr miceExonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice.The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.Transcriptome profiling reveals distinctive traits of retinol metabolism and neonatal parallels in the MRL/MpJ mouse.MRL Strains Have a BAFFR Mutation without Functional Consequence.Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor γ.Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus.Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.HDAC expression and activity is upregulated in diseased lupus-prone mice.Epidermal injury promotes nephritis flare in lupus-prone mice.Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.
P2860
Q26749296-C7486276-42C3-409C-A6AD-3A37E15E6049Q26774654-92DAD1C1-2C17-46FB-9987-ECFD856CAC2AQ26781300-F57D69E8-3FA6-4225-97D0-95FEB444FF5BQ26824461-4E75A2DA-5E98-4E7B-ACE6-0A3D9ADF0A95Q27319435-F13E22F4-AC78-4C90-8DE0-2610C52D0A4DQ28076199-813EF8D8-C10E-4B62-B947-6DE747496A13Q28083593-4FF22A17-1087-40A4-97A5-421A4DCADA0FQ28088753-092DB190-9E08-4761-B07A-CC67C985BDA3Q28394117-0483F705-E913-4E11-B8A5-A08CA2BC2F99Q28649846-EAFFFA4A-A660-449D-AE93-917A4F7E66B6Q30360682-0374E066-E1B1-4B33-81BC-B646A577842EQ33859906-133EF206-8CE1-4818-8BAF-D6C7339D7206Q33861809-4CEF3267-35A1-4BD9-B3DB-BEE9DF656C5BQ34015403-C745AEDE-5762-49EE-AAA0-B90C1B7F0D37Q34146380-C0EB8593-718F-4527-AC52-CBDA635E3712Q34230520-391EAFE8-FAA9-4B40-8CEC-63BDBCFE41A8Q34595444-22DCE6A5-FC24-49C0-905F-3DA82DFE18A6Q34623271-8A5A104C-4858-40D3-9B3A-118F205AC0ABQ34790990-0088F302-CCBC-444B-A974-8818AF25142CQ35035048-6A4D91B8-1F5E-4323-A788-65D3C3DCE684Q35060808-2EF42400-7276-48FF-BDAC-2832DF9E215CQ35071158-53BBFF2F-811F-4E0F-A7C9-6E617B323743Q35182476-22B8C356-6D6A-4C7F-AAB0-53D40F86FF84Q35418333-DFAE1028-F733-4C00-950B-1B0A0C87D8A4Q35538362-B10AA04F-783D-424A-A813-D4FB9CA75FBFQ35549308-5B25E85D-C130-4207-A5C5-00F2924ED832Q35565080-FE939ABD-6CEB-4810-AFDB-44218F6FFF50Q35606420-D653EA7C-C844-4E14-A9EC-5497C507CB7DQ35622999-D4CF9E7C-9F47-46B2-B9FF-794BE7042E19Q35842637-3514D770-B238-4979-8843-9A3000D9C219Q36009582-A42BDC08-8C97-4D6F-909E-9C7F4291AAE5Q36010662-0D914E30-CC72-44A9-81A3-CF671DD8EB7AQ36012345-F6E8F125-58AF-43CB-9EA6-20947ABCFD82Q36065912-6B30A841-A0FD-4386-B380-4822DEA32E27Q36084002-1A835702-EE1B-4430-A744-D9A5A27FE2CBQ36291643-D8F65E9C-4690-491A-8894-3DA5B1B18B8AQ36295343-C53FEFAE-E784-4C84-8C0B-78660B1394A3Q36338516-3CB8039E-0E10-4820-A67C-CC30DA0D0AFFQ36373291-F533DAF1-06B4-40BF-86A8-CEDC035A3154Q36409505-F39B84CB-5DE8-422E-AA87-66A95FD7F3A6
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Murine models of systemic lupus erythematosus
@en
Murine models of systemic lupus erythematosus
@nl
type
label
Murine models of systemic lupus erythematosus
@en
Murine models of systemic lupus erythematosus
@nl
prefLabel
Murine models of systemic lupus erythematosus
@en
Murine models of systemic lupus erythematosus
@nl
P2093
P2860
P921
P356
P1476
Murine models of systemic lupus erythematosus
@en
P2093
Allison Sang
Laurence Morel
Yiming Yin
Ying-Yi Zheng
P2860
P304
P356
10.1155/2011/271694
P577
2011-02-14T00:00:00Z